three activated upstream regulators are cigarette smoke (z-score = 2.577), benzo [a]pyrene (z-score = 2.905), and nuclear factor (erythroid-derived 2)-like 2 (NFE2L2, Nrf2) (z-score = 2.531). Analysis of downstream effects indicated that growth of epithelial tissue was predicted to be increased (z-score = 2.813; P , 0.001). The top three canonical pathways included xenobiotic metabolism signaling, aryl hydrocarbon receptor signaling, and nicotine degradation III.
Rationale: Evidence has shown that inhaled lung carcinogens, such as tobacco smoke, silica, or asbestos, induce a T-helper cell type 17 inflammatory environment. Interleukin-17A (commonly and hereafter called IL-17) is the signature cytokine of T-helper cell type 17 inflammation. We have shown previously that IL-17 overexpression promotes growth of lung adenocarcinoma in transgenic mouse models. Our additional findings suggest that IL-17 suppresses the function of the p53 tumor suppressor protein in a mutant K-Ras-expressing lung tumor cell line.
Objectives:
To compare our studies in mice to clinical samples.
Methods:
We have used informatics and RNA sequencing-based approaches to analyze primary human lung adenocarcinoma samples.
Results: Comprehensive transcriptome analyses have shown that IL-17 expression positively correlates with expression of serine/ arginine-rich splicing factor 1 (SRSF1), a key cellular splicing factor. This observation correlates with our previous finding that IL-17 regulates the activity of serine/argininerich splicing factor 1. In accord, there are significant differences in the global splicing activity between the IL-17 1 and IL-17 2 lung adenocarcinomas, indicating that IL-17 may affect the selectivity of RNA splicing events by targeting serine/argininerich splicing factor 1. Further, Ingenuity pathway analyses (Qiagen) have identified activation of key pathways in IL-17 1 relative to IL17 2 lung adenocarcinomas. In these analyses, IL-18 signaling appears central to IL-17 1 lung adenocarcinomas, which display prominent signatures related to inflammation and evasion of antitumor immunity.
